Re:NewCell AB (publ) Logo

Re:NewCell AB (publ)

RENEW.ST

(1.8)
Stock Price

5,30 SEK

-19.88% ROA

-49.13% ROE

-0.54x PER

Market Cap.

218.649.910,00 SEK

142.06% DER

0% Yield

-195.56% NPM

Re:NewCell AB (publ) Stock Analysis

Re:NewCell AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Re:NewCell AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.38x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-55.51%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-20.29%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 DER

The stock is burdened with a heavy load of debt (142%), making it financially unstable and potentially risky for investors.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-4), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Re:NewCell AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Re:NewCell AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Re:NewCell AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Re:NewCell AB (publ) Revenue
Year Revenue Growth
2017 0
2018 0 0%
2019 750.000 100%
2020 1.453.000 48.38%
2021 3.573.000 59.33%
2022 13.805.000 74.12%
2023 337.600.000 95.91%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Re:NewCell AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2017 0
2018 0 0%
2019 0 0%
2020 0 0%
2021 3.142.000 100%
2022 3.101.000 -1.32%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Re:NewCell AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2017 17.525.000
2018 10.455.000 -67.62%
2019 18.502.000 43.49%
2020 31.881.000 41.97%
2021 41.456.000 23.1%
2022 38.105.000 -8.79%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Re:NewCell AB (publ) EBITDA
Year EBITDA Growth
2017 -18.661.000
2018 -17.849.000 -4.55%
2019 -30.073.000 40.65%
2020 -61.306.000 50.95%
2021 -120.231.000 49.01%
2022 -251.154.000 52.13%
2023 -196.800.000 -27.62%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Re:NewCell AB (publ) Gross Profit
Year Gross Profit Growth
2017 0
2018 0 0%
2019 -3.656.000 100%
2020 -6.157.000 40.62%
2021 -12.277.000 49.85%
2022 -68.477.000 82.07%
2023 -5.600.000 -1122.8%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Re:NewCell AB (publ) Net Profit
Year Net Profit Growth
2017 -23.210.000
2018 -18.418.000 -26.02%
2019 -38.188.000 51.77%
2020 -69.181.000 44.8%
2021 -138.971.000 50.22%
2022 -299.936.000 53.67%
2023 -378.000.000 20.65%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Re:NewCell AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2017 -1
2018 -1 0%
2019 -1 100%
2020 -3 66.67%
2021 -5 25%
2022 -8 50%
2023 -9 11.11%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Re:NewCell AB (publ) Free Cashflow
Year Free Cashflow Growth
2017 -56.371.000
2018 -29.941.000 -88.27%
2019 -32.082.000 6.67%
2020 -85.093.000 62.3%
2021 -429.869.000 80.2%
2022 -1.277.691.000 66.36%
2023 -87.700.000 -1356.89%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Re:NewCell AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2017 -21.576.000
2018 -18.980.000 -13.68%
2019 -31.109.000 38.99%
2020 -51.990.000 40.16%
2021 -117.695.000 55.83%
2022 -397.918.000 70.42%
2023 -83.500.000 -376.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Re:NewCell AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2017 34.795.000
2018 10.961.000 -217.44%
2019 973.000 -1026.52%
2020 33.103.000 97.06%
2021 312.174.000 89.4%
2022 879.773.000 64.52%
2023 4.200.000 -20846.98%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Re:NewCell AB (publ) Equity
Year Equity Growth
2017 63.611.000
2018 73.993.000 14.03%
2019 89.570.000 17.39%
2020 800.369.000 88.81%
2021 674.234.000 -18.71%
2022 863.903.000 21.95%
2023 797.700.000 -8.3%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Re:NewCell AB (publ) Assets
Year Assets Growth
2017 79.904.000
2018 88.934.000 10.15%
2019 103.963.000 14.46%
2020 827.287.000 87.43%
2021 1.115.133.000 25.81%
2022 1.835.245.000 39.24%
2023 2.027.000.000 9.46%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Re:NewCell AB (publ) Liabilities
Year Liabilities Growth
2017 16.293.000
2018 14.941.000 -9.05%
2019 14.393.000 -3.81%
2020 26.918.000 46.53%
2021 440.899.000 93.89%
2022 971.342.000 54.61%
2023 1.229.300.000 20.98%

Re:NewCell AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.01
Net Income per Share
-9.79
Price to Earning Ratio
-0.54x
Price To Sales Ratio
1.07x
POCF Ratio
-0.64
PFCF Ratio
-0.38
Price to Book Ratio
0.27
EV to Sales
6.09
EV Over EBITDA
-4.44
EV to Operating CashFlow
-3.66
EV to FreeCashFlow
-2.16
Earnings Yield
-1.85
FreeCashFlow Yield
-2.64
Market Cap
0,22 Bil.
Enterprise Value
1,25 Bil.
Graham Number
65.46
Graham NetNet
-25.13

Income Statement Metrics

Net Income per Share
-9.79
Income Quality
0.94
ROE
-0.49
Return On Assets
-0.2
Return On Capital Employed
-0.21
Net Income per EBT
1
EBT Per Ebit
1.11
Ebit per Revenue
-1.77
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
-0
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.4
Operating Profit Margin
-1.77
Pretax Profit Margin
-1.96
Net Profit Margin
-1.96

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-8.33
Free CashFlow per Share
-14.09
Capex to Operating CashFlow
0.69
Capex to Revenue
-1.15
Capex to Depreciation
-2.99
Return on Invested Capital
-0.19
Return on Tangible Assets
-0.2
Days Sales Outstanding
98.02
Days Payables Outstanding
62.68
Days of Inventory on Hand
139.03
Receivables Turnover
3.72
Payables Turnover
5.82
Inventory Turnover
2.63
Capex per Share
-5.76

Balance Sheet

Cash per Share
2,51
Book Value per Share
19,46
Tangible Book Value per Share
19.24
Shareholders Equity per Share
19.46
Interest Debt per Share
28.67
Debt to Equity
1.42
Debt to Assets
0.56
Net Debt to EBITDA
-3.66
Current Ratio
1.38
Tangible Asset Value
0,79 Bil.
Net Current Asset Value
-0,83 Bil.
Invested Capital
1.42
Working Capital
0,11 Bil.
Intangibles to Total Assets
0
Average Receivables
0,16 Bil.
Average Payables
0,06 Bil.
Average Inventory
125050000
Debt to Market Cap
5.18

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Re:NewCell AB (publ) Dividends
Year Dividends Growth

Re:NewCell AB (publ) Profile

About Re:NewCell AB (publ)

Re:NewCell AB (publ) operates as a textile recycling company in Sweden. It produces and sells dissolving pulp from recycled textiles under the Circulose brand. The company sells its dissolving pulp products to producers of regenerated fiber, such as viscose, modal, and lyocell. Re:NewCell AB (publ) was founded in 2012 and is headquartered in Stockholm, Sweden.

CEO
Mr. Magnus HÃ¥kansson
Employee
123
Address
Cardellgatan 1
Stockholm, 114 36

Re:NewCell AB (publ) Executives & BODs

Re:NewCell AB (publ) Executives & BODs
# Name Age
1 Mr. Martin Stenfors
Head of Strategy & Sustainability
70
2 Ms. Tricia Carey
Chief Commercial Officer
70
3 Mr. Peter Schulz
Interim Chief Financial Officer
70
4 Mr. Magnus Lundmark
Chief Operation Officer
70
5 Mr. Magnus HÃ¥kansson
Acting Chief Executive Officer
70

Re:NewCell AB (publ) Competitors

Azelio AB (publ) Logo
Azelio AB (publ)

AZELIO.ST

(1.2)
Sinch AB (publ) Logo
Sinch AB (publ)

SINCH.ST

(2.5)
Cint Group AB (publ) Logo
Cint Group AB (publ)

CINT.ST

(1.2)